Vancouver, Canada · Founded 2018 · Privately Held (backing)
Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. Bold Therapeutics is based in Vancouver, Canada and was founded in 2018. Its last known valuation is $140 million. It has raised $25 million across 1 recorded round; the latest was a $5.5 million early-stage round in Jul 2018.
Last price · $/share
—
Implied valuation
$140.0M
Total raised
$25.0M
Last round
Early Stage VC
Jul 2018
No prints on record
No secondary trades in Bold Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bold Therapeutics with a free account
·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Bold Therapeutics stock.
